Pembrolizumab Plus Ipilimumab or Placebo for Metastatic Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50%: Randomized, Double-Blind Phase III KEYNOTE-598 Study
Boyer, Michael, Şendur, Mehmet A N, Rodríguez-Abreu, Delvys, Park, Keunchil, Lee, Dae Ho, Çiçin, Irfan, Yumuk, Perran Fulden, Orlandi, Francisco J, Leal, Ticiana A, Molinier, Olivier, Soparattanapaisarn, Nopadol, Langleben, Adrian, Califano, Raffaele, Medgyasszay, Balazs, Hsia, Te-Chun, Otterson, Gregory A, Xu, Lu, Piperdi, Bilal, Samkari, Ayman, Reck, Martin
Published in Journal of clinical oncology (20.07.2021)
Published in Journal of clinical oncology (20.07.2021)
Get full text
Journal Article
Palbociclib in HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer: A Systematic Scoping Review of Real-World Evidence from Countries Outside of Western Regions that Are Underrepresented in Clinical Trials
Rauthan, Amit, Jain, Ankita, Singh, Manmohan, Sendur, Mehmet A. N.
Published in Oncology and therapy (01.09.2024)
Published in Oncology and therapy (01.09.2024)
Get full text
Journal Article
Cardiotoxicity of novel HER2-targeted therapies
Sendur, Mehmet A N, Aksoy, Sercan, Altundag, Kadri
Published in Current medical research and opinion (01.08.2013)
Published in Current medical research and opinion (01.08.2013)
Get more information
Journal Article
Trastuzumab emtansine (T-DM1) for HER2-positive breast cancer
Boyraz, Baris, Sendur, Mehmet A N, Aksoy, Sercan, Babacan, Taner, Roach, Emir C, Kizilarslanoglu, Muhammet C, Petekkaya, Ibrahim, Altundag, Kadri
Published in Current medical research and opinion (01.04.2013)
Published in Current medical research and opinion (01.04.2013)
Get more information
Journal Article
Everolimus: a new hope for patients with breast cancer
Sendur, Mehmet A N, Zengin, Nurullah, Aksoy, Sercan, Altundag, Kadri
Published in Current medical research and opinion (01.01.2014)
Published in Current medical research and opinion (01.01.2014)
Get more information
Journal Article
Actual benefit of chemo-hormonal therapy in non-castrate metastatic prostate cancer
endur, Mehmet AN, Ak nc, Muhammed Bülent, Ozdemir, Nuriye Y ld r m, Aksoy, Sercan, Dede, Didem S, Ulas, Arife, Zengin, Nurullah, Yalç n, Bülent
Published in Future oncology (London, England) (01.04.2015)
Published in Future oncology (London, England) (01.04.2015)
Get full text
Journal Article
Pertuzumab-induced cardiotoxicity: safety compared with trastuzumab
Sendur, Mehmet AN, Aksoy, Sercan, Altundag, Kadri
Published in Future oncology (London, England) (01.01.2015)
Published in Future oncology (London, England) (01.01.2015)
Get full text
Journal Article
Resistance to Androgen-Pathway Drugs in Prostate Cancer
Şendur, Mehmet A.N, Akıncı, Muhammed B, Yalçın, Bülent, Ozaki, Yukinori, Miura, Yuji, Takano, Toshimi, Steinestel, Julie, Schrader, Andres J, Luedeke, Manuel, Antonarakis, Emmanuel S, Nakazawa, Mary, Luo, Jun
Published in The New England journal of medicine (04.12.2014)
Published in The New England journal of medicine (04.12.2014)
Get full text
Journal Article
Docetaxel or abiraterone in addition to androgen deprivation therapy in metastatic castration-sensitive prostate cancer
Bilgin, Burak, endur, Mehmet AN, H zal, Mutlu, Ak nc, Muhammed Bülent, ener Dede, Didem, Yalç n, Bulent
Published in Future oncology (London, England) (01.09.2017)
Published in Future oncology (London, England) (01.09.2017)
Get full text
Journal Article
The current status of adjuvant treatment for high-risk renal cell carcinoma
H zal, Mutlu, endur, Mehmet AN, Bilgin, Burak, Ak nc, Muhammed Bülent, ener Dede, Didem, Yalç n, Bulent
Published in Future oncology (London, England) (01.10.2017)
Published in Future oncology (London, England) (01.10.2017)
Get full text
Journal Article
Do all aromatase inhibitors have similar efficacy and safety?
endur, Mehmet AN, Bilgin, Burak, H zal, Mutlu, Özdemir, Nuriye Y ld r m, Ak nc, Muhammed Bülent, Dede, Didem ener, Yalç n, Bulent
Published in Future oncology (London, England) (01.08.2017)
Published in Future oncology (London, England) (01.08.2017)
Get full text
Journal Article
Neutrophil-lymphocyte ratio as a prognostic factor for survival in patients with advanced renal cell carcinoma (Turkish Oncology Group Study)
Hizal, Mutlu, Sendur, Mehmet An, Yasar, Hatime Arzu, Bir Yucel, Kadriye, Arslan, Cagatay, Ucar, Gokhan, Karakaya, Serdar, Taban, Hakan, Kucukarda, Ahmet, Erturk, Ismail, Bilgin, Burak, Yıldırım, Nuriye, Demirci, Umut, Kılıckap, Saadettin, Cicin, Irfan, Karadurmus, Nuri, Yalcin, Bulent, Ürün, Yüksel
Published in Journal of oncology pharmacy practice (01.10.2020)
Published in Journal of oncology pharmacy practice (01.10.2020)
Get more information
Journal Article
Selective internal radiation therapy in untreated patients with unresectable liver dominant metastatic colorectal cancer
endur, Mehmet AN, Bilgin, Burak, Ak nc, Muhammed B, Dede, Didem Sener, Özdemir, Nuriye, Ulas, Arife, Zengin, Nurullah, Yalç n, Bulent
Published in Future oncology (London, England) (01.02.2017)
Published in Future oncology (London, England) (01.02.2017)
Get full text
Journal Article
Necrotizing fasciitis secondary to bevacizumab treatment for metastatic rectal adenocarcinoma
Sendur, Mehmet, Aksoy, Sercan, Özdemir, Nuriye, Zengin, Nurullah
Published in Indian journal of pharmacology (01.01.2014)
Published in Indian journal of pharmacology (01.01.2014)
Get full text
Journal Article
Pertuzumab plus Trastuzumab in Metastatic Breast Cancer
Şendur, Mehmet A.N, Aksoy, Sercan, Zengin, Nurullah, Li-Wan-Po, Alain, Revannasiddaiah, Swaroop, Seam, Rajeev, Gupta, Manoj, Baselga, José, Benyunes, Mark C, Swain, Sandra M
Published in The New England journal of medicine (05.04.2012)
Published in The New England journal of medicine (05.04.2012)
Get full text
Journal Article
Adjuvant Capecitabine for Breast Cancer
Hizal, Mutlu, Şendur, Mehmet A N, Yalçin, Bülent
Published in The New England journal of medicine (24.08.2017)
Get full text
Published in The New England journal of medicine (24.08.2017)
Journal Article
An update on immunotherapy options for urothelial cancer
Bilgin, Burak, Sendur, Mehmet A N, Hizal, Mutlu, Yalçın, Bülent
Published in Expert opinion on biological therapy (02.12.2019)
Published in Expert opinion on biological therapy (02.12.2019)
Get more information
Journal Article